Several methods to model human Ph+ leukemia in laboratory mice are availabl
e, including propagation of BCR/ABL-expressing cells in mice, xenotransplan
tation of primary Ph+ leukemia cells into immunodeficient mice, BCR/ABL tra
nsgenic mice, and BCR/ABL retroviral bone marrow transduction and transplan
tation. Recent studies in these different model systems have yielded import
ant advances in our knowledge of the pathogenesis and therapy of human chro
nic myeloid leukemia and Ph+ B-lymphoblastic leukemia, and are the subject
of this review. (C) 2001 Lippincott Williams & Wilkins, Inc.